Search Results for: NCM-MCI-6.5 Tests 🍟 NCM-MCI-6.5 Online Test 🍰 NCM-MCI-6.5 Demotesten 📔 Suchen Sie jetzt auf ▶ www.itzert.com ◀ nach ▛ NCM-MCI-6.5 ▟ und laden Sie es kostenlos herunter 😭NCM-MCI-6.5 Zertifizierungsfragen
Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).
Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). by Pfaller MA,…
Importance of understanding pharmacokinetic/pharmocodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus.
Importance of understanding pharmacokinetic/pharmocodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus. by Fritsche TR and Jones RN published in J. Drugs Dermatol. 2005; 4 (Suppl 6): s4-s8…
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric Gram- negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric Gram- negative bacilli: Occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. by…
Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012). by Pfaller MA, Messer SA, Jones…
Echinocandin and triazole antifungal susceptibility profiles for Candida spp. Cryptococcus neoformans, and Aspergillus fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
Echinocandin and triazole antifungal susceptibility profiles for Candida spp. Cryptococcus neoformans, and Aspergillus fumigatus: Application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY…
Identification of a novel cephalosporinase (DHA-3) in Klebsiella pneumoniae isolated in Taiwan.
Identification of a novel cephalosporinase (DHA-3) in Klebsiella pneumoniae isolated in Taiwan. by Wu LT, Hung SW, Chuang YC, Chen HE, Jones RN and Yu WL published in Clin. Microbiol….
Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY Antimicrobial Surveillance Program (1998-99).
Prevalence of extended spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: Regional results from SENTRY Antimicrobial Surveillance Program (1998-99). by Bell JM, Turnidge JD, Gales AC,…
Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group. by Jones RN, Salazar JC, Pfaller MA and Doern…
In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae.
In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae. by Farrell DJ, Sader HS, Rhomberg PR, Scangarella-Oman NE and Flamm RK published in Antimicrob. Agents Chemother. 2017; 61 (3): e02047…
Dalbavancin in vitro activity obtained against gram-positive clinical isolates causing bone and joint infections in United States and European hospitals (2011-2016).
Dalbavancin in vitro activity obtained against gram-positive clinical isolates causing bone and joint infections in United States and European hospitals (2011-2016). by Pfaller MA, Flamm RK, Castanheira M, Sader HS…
